Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)

NCT02687035 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT02687035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02687035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves: Continued Access Program for SAPIEN 3 Intermediate Risk (S3iCAP)
Lead sponsor
Edwards Lifesciences
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2015
Completion date
December 31, 2018
Enrollment
1,822 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis